查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2019785

流式細胞技術市場規模、佔有率、成長及全球產業分析：按類型、應用和地區的洞察，2026-2034年的預測

Flow Cytometry Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 148 Pages | 商品交期: 請詢問到貨日

價格

流式細胞技術市場成長要素

受對先進診斷和研究工具需求不斷成長的推動，全球流式細胞技術市場正經歷強勁成長。預計到2025年，該市場規模將達到66.6億美元，2026年將成長至72.2億美元，到2034年將達到141.2億美元。這一顯著成長反映了流式細胞技術在疾病診斷、藥物研發和臨床研究領域日益廣泛的應用。

流式細胞技術是一種強大的分析技術，它利用雷射檢測來測量細胞和顆粒的物理和化學性質。它在細胞計數、生物標記檢測和疾病診斷中發揮著非常重要的作用，尤其是在腫瘤學、免疫學和感染疾病領域。

市場趨勢

推動市場發展的關鍵趨勢之一是新一代流式細胞技術系統的研發。這些先進的儀器能夠進行多參數分析，使研究人員可以同時研究多種細胞特性。最新的系統可以同時分析20到30個參數，進而提高疾病檢測的準確性並提升研究成果。

自動化也是一項關鍵趨勢，各公司紛紛採用機器人樣本製備系統和整合解決方案來提高效率和可重複性。此外，先進軟體和人工智慧的融合簡化資料分析並改善臨床決策。

市場成長要素

流式細胞技術市場的成長主要受癌症、愛滋病和白血病等慢性疾病日益普遍的驅動。隨著疾病負擔的加重，人們對能夠提供準確快速結果的先進診斷技術的需求也日益成長。

另一個重要因素是研發投入的增加。製藥和生物技術公司擴大將流式細胞技術應用於藥物發現、免疫腫瘤學和幹細胞研究。重組DNA技術和抗體研究的日益普及也進一步推動了市場需求。

此外，人們對早期疾病診斷重要性的認知不斷提高，以及先進檢測技術的引進，推動流式細胞技術在臨床和研究環境中的廣泛應用。

抑制因子

儘管流式細胞儀具有諸多優勢，但市場仍面臨一些挑戰。流式細胞技術設備高成本，從7.5萬美元到10萬美元不等，這限制了其普及應用，尤其是在小規模檢查室和發展中地區。

此外，技術複雜性和對專業技術人員的需求限制了其廣泛應用。設備體積較大和維護要求較高也阻礙了市場成長。這些因素可能會在對成本敏感的市場中減緩其普及速度。

細分分析

依產品/服務

市場區隔分為儀器、耗材和試劑以及軟體和服務。受分析儀器和細胞分選儀需求不斷成長的推動，儀器細分市場預計將佔據主導地位，到2026年將佔市場佔有率的50.48%。這些儀器技術的不斷進步也促進了它們的廣泛應用。

依技術

依技術分類，市場可分為基於細胞的系統和以微珠為基礎的系統。預計到2026年，基於細胞的系統將佔據市場主導地位，市場佔有率達到59.83%，這主要得益於其在疾病診斷中的廣泛應用。同時，以微珠為基礎的技術因其高靈敏度和成本效益，預計將快速成長。

依用途

目前，研究領域佔最大佔有率，預計到2026年將達到70.32%，主要得益於生命科學和生物技術研究領域投資的增加。臨床領域也因診斷應用需求的成長而發展壯大。

最終用戶

醫院和診斷檢查室是這一細分市場的主要驅動力，預計到2026年將佔市場佔有率的36.52%，這主要得益於患者數量的增加和對準確診斷工具日益成長的需求。

區域趨勢

北美地區擁有許多主要企業和先進的醫療基礎設施，2025年引領全球流式細胞技術市場，佔39.42%的市場佔有率。該地區透過高額的研發投入和對先進技術的早期應用，持續保持其主導地位。

歐洲佔據較大佔有率，這主要得益於活性化的研究活動和監管機構的核准。亞太地區預計將實現最快成長，這主要得益於健康意識的提高、研究能力的增強以及先進診斷工具的日益普及。

拉丁美洲、中東和非洲的市場逐步成長，這得益於醫療基礎設施的改善和慢性病盛行率的上升。

目錄

第1章 引言

第2章 執行摘要

第3章 市場動態

  • 市場促進因素
  • 市場限制因素
  • 市場機會
  • 市場趨勢

第4章 主要考察

  • 2025年主要國家愛滋病毒和癌症盛行率
  • 流式細胞技術的技術進步
  • 產業重大發展動態 - 併購、聯盟與收購
  • 新冠疫情的影響：全球流式細胞技術市場

第5章 2021-2034年全球流式細胞技術市場分析、洞察與預測

  • 市場分析、洞察與預測：依產品和服務分類。
    • 裝置
      • 分析器
      • 分類機
    • 試劑和耗材
    • 軟體服務
  • 市場分析、洞察與預測：依技術分類
    • 基於細胞
    • 基於微珠
  • 市場分析、洞察與預測：依應用領域分類
    • 臨床階段
    • 研究
  • 市場分析、洞察與預測：依最終用戶分類
    • 製藥和生物技術產業
    • 學術和研究機構
    • 醫院/診斷
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區

第6章 北美流式細胞技術市場分析、洞察與預測（2021-2034年）

  • 國家
    • 美國
    • 加拿大

第7章 歐洲流式細胞技術市場分析、洞察與預測（2021-2034年）

  • 國家
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 斯堪地那維亞
    • 其他歐洲國家

第8章 亞太地區流式細胞技術市場分析、洞察與預測（2021-2034年）

  • 國家
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家

第9章 2021-2034年世界其他地區流式細胞技術市場分析、洞察及預測

第10章 競爭分析

  • 全球市場佔有率分析（2025年）
  • 公司簡介
    • Miltenyi Biotec
    • BD（Becton, Dickinson and Company）
    • Bio-Rad Laboratories, Inc.
    • Thermo Fisher Scientific Inc.
    • Agilent Technologies, Inc.
    • Sysmex Corporation
    • Apogee Flow Systems Ltd.
    • Sony Biotechnology Inc.
    • DiaSorin SpA
    • BIOMERIEUX
Product Code: FBI107325

Growth Factors of flow cytometry Market

The global flow cytometry market is experiencing strong growth due to increasing demand for advanced diagnostic and research tools. The market was valued at USD 6.66 billion in 2025 and is projected to grow to USD 7.22 billion in 2026, reaching USD 14.12 billion by 2034. This significant expansion reflects the growing application of flow cytometry in disease diagnosis, drug discovery, and clinical research.

Flow cytometry is a powerful analytical technology used to measure physical and chemical characteristics of cells or particles using laser-based detection. It plays a crucial role in cell counting, biomarker detection, and disease diagnosis, particularly in oncology, immunology, and infectious diseases.

Market Trends

One of the major trends shaping the market is the development of next-generation flow cytometry systems. These advanced instruments allow multi-parameter analysis, enabling researchers to study multiple cellular characteristics simultaneously. Modern systems can analyze 20-30 parameters at once, improving accuracy in disease detection and research outcomes.

Automation is another key trend, with companies introducing robotic sample preparation systems and integrated solutions that enhance efficiency and reproducibility. Additionally, the integration of advanced software and artificial intelligence is streamlining data analysis and improving clinical decision-making.

Market Growth Drivers

The growth of the flow cytometry market is primarily driven by the increasing prevalence of chronic diseases such as cancer, HIV/AIDS, and leukemia. The rising disease burden has led to higher demand for advanced diagnostic technologies that provide accurate and rapid results.

Another important driver is the growing investment in research and development. Pharmaceutical and biotechnology companies are increasingly using flow cytometry in drug discovery, immuno-oncology, and stem cell research. The expanding use of recombinant DNA technology and antibody-based research is further boosting market demand.

Moreover, the increased awareness regarding early disease diagnosis and the adoption of advanced laboratory technologies are supporting the widespread use of flow cytometry across clinical and research settings.

Restraining Factors

Despite its advantages, the market faces certain challenges. The high cost of flow cytometry instruments, ranging between USD 75,000 and USD 100,000, limits adoption, especially in small laboratories and developing regions.

Additionally, the technical complexity and requirement for skilled professionals restrict its widespread usage. The bulky nature of instruments and maintenance requirements also act as barriers to market growth. These factors may slow down adoption in cost-sensitive markets.

Segmentation Analysis

By Product & Service

The market is segmented into instruments, consumables & reagents, and software & services. The instruments segment dominates with a 50.48% share in 2026, driven by increasing demand for analyzers and cell sorters. Continuous technological advancements in these instruments support their widespread adoption.

By Technology

Based on technology, the market is divided into cell-based and bead-based systems. The cell-based segment leads with a 59.83% share in 2026, owing to its extensive use in disease diagnosis. Meanwhile, bead-based technology is expected to grow rapidly due to its high sensitivity and cost-effectiveness.

By Application

The research segment holds the largest share, accounting for 70.32% in 2026, driven by increasing investments in life sciences and biotechnology research. The clinical segment is also growing due to rising demand for diagnostic applications.

By End-user

Hospitals and diagnostic laboratories dominate the segment with a 36.52% share in 2026, supported by increasing patient visits and growing need for accurate diagnostic tools.

Regional Insights

North America dominates the global flow cytometry market, accounting for 39.42% share in 2025, with a strong presence of key players and advanced healthcare infrastructure. The region continues to lead due to high R&D investments and early adoption of advanced technologies.

Europe holds a significant share, driven by increasing research activities and regulatory approvals. Asia Pacific is expected to witness the fastest growth due to rising healthcare awareness, expanding research capabilities, and increasing adoption of advanced diagnostic tools.

Latin America and the Middle East & Africa are gradually growing markets, supported by improving healthcare infrastructure and rising prevalence of chronic diseases.

Conclusion

The flow cytometry market is set for robust growth, expanding from USD 6.66 billion in 2025 to USD 14.12 billion by 2034. The growth is driven by increasing prevalence of chronic diseases, technological advancements, and rising research activities. While high costs and technical complexities pose challenges, ongoing innovations and expanding applications in clinical and research fields are expected to drive long-term market expansion. Overall, the market presents significant opportunities for stakeholders in the healthcare and life sciences sectors.

Segmentation By Product & Service

  • Instruments
    • Analyzer
    • Sorter
  • Reagents & Consumables
  • Software & Services

By Technology

  • Cell Based
  • Bead Based

By Application

  • Clinical
  • Research

By End-user

  • Pharmaceutical & Biotechnology Industries
  • Academic & Research Organizations
  • Hospital & Diagnostics
  • Others

By Geography

  • North America (By Product & Service, By Technology, By Application, By Country)
    • U.S. (By Application)
    • Canada (By Application)
  • Europe (By Product & Service, By Technology, By Application, By Country/sub-region)
    • Germany (By Application)
    • U.K. (By Application)
    • France (By Application)
    • Italy (By Application)
    • Spain (By Application)
    • Scandinavia (By Application)
    • Rest of Europe (By Application)
  • Asia Pacific (By Product & Service, By Technology, By Application, By Country/sub-region)
    • China (By Application)
    • Japan (By Application)
    • India (By Application)
    • Australia (By Application)
    • Southeast Asia (By Application)
    • Rest of Asia Pacific (By Application)
  • Rest of the World

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of HIV and Cancer, By Key Countries, 2025
  • 4.2. Technological Advancements in Flow Cytometry
  • 4.3. Key Industry Developments -Mergers, Partnerships, & Acquisitions
  • 4.4. Impact of COVID-19 on Global Flow Cytometry Market

5. Global Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product & Service
    • 5.1.1. Instruments
      • 5.1.1.1. Analyzer
      • 5.1.1.2. Sorter
    • 5.1.2. Reagents & Consumables
    • 5.1.3. Software & Services
  • 5.2. Market Analysis, Insights and Forecast - By Technology
    • 5.2.1. Cell Based
    • 5.2.2. Bead Based
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Clinical
    • 5.3.2. Research
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Pharmaceuticals & Biotechnology Industries
    • 5.4.2. Academic & Research Organizations
    • 5.4.3. Hospitals & Diagnostics
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Rest of the World

6. North America Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product & Service
    • 6.1.1. Instruments
      • 6.1.1.1. Analyzer
      • 6.1.1.2. Sorter
    • 6.1.2. Reagents & Consumables
    • 6.1.3. Software & Services
  • 6.2. Market Analysis, Insights and Forecast - By Technology
    • 6.2.1. Cell Based
    • 6.2.2. Bead Based
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Clinical
    • 6.3.2. Research
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Pharmaceuticals & Biotechnology Industries
    • 6.4.2. Academic & Research Organizations
    • 6.4.3. Hospitals & Diagnostics
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Application
    • 6.5.2. Canada
      • 6.5.2.1. By Application

7. Europe Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product & Service
    • 7.1.1. Instruments
      • 7.1.1.1. Analyzer
      • 7.1.1.2. Sorter
    • 7.1.2. Reagents & Consumables
    • 7.1.3. Software & Services
  • 7.2. Market Analysis, Insights and Forecast - By Technology
    • 7.2.1. Cell Based
    • 7.2.2. Bead Based
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Clinical
    • 7.3.2. Research
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Pharmaceuticals & Biotechnology Industries
    • 7.4.2. Academic & Research Organizations
    • 7.4.3. Hospitals & Diagnostics
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. U.K.
      • 7.5.1.1. By Application
    • 7.5.2. Germany
      • 7.5.2.1. By Application
    • 7.5.3. France
      • 7.5.3.1. By Application
    • 7.5.4. Italy
      • 7.5.4.1. By Application
    • 7.5.5. Spain
      • 7.5.5.1. By Application
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Application
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Application

8. Asia Pacific Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product & Service
    • 8.1.1. Instruments
      • 8.1.1.1. Analyzer
      • 8.1.1.2. Sorter
    • 8.1.2. Reagents & Consumables
    • 8.1.3. Software & Services
  • 8.2. Market Analysis, Insights and Forecast - By Technology
    • 8.2.1. Cell Based
    • 8.2.2. Bead Based
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Clinical
    • 8.3.2. Research
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Pharmaceuticals & Biotechnology Industries
    • 8.4.2. Academic & Research Organizations
    • 8.4.3. Hospitals & Diagnostics
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. Japan
      • 8.5.1.1. By Application
    • 8.5.2. China
      • 8.5.2.1. By Application
    • 8.5.3. India
      • 8.5.3.1. By Application
    • 8.5.4. Australia
      • 8.5.4.1. By Application
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Application
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Application

9. Rest of the World Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product & Service
    • 9.1.1. Instruments
      • 9.1.1.1. Analyzer
      • 9.1.1.2. Sorter
    • 9.1.2. Reagents & Consumables
    • 9.1.3. Software & Services
  • 9.2. Market Analysis, Insights and Forecast - By Technology
    • 9.2.1. Cell Based
    • 9.2.2. Bead Based
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Clinical
    • 9.3.2. Research
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Pharmaceuticals & Biotechnology Industries
    • 9.4.2. Academic & Research Organizations
    • 9.4.3. Hospitals & Diagnostics
    • 9.4.4. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Miltenyi Biotec
      • 10.2.1.1. Overview
      • 10.2.1.2. Products & Services
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. BD (Becton, Dickinson and Company)
      • 10.2.2.1. Overview
      • 10.2.2.2. Products & Services
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Bio-Rad Laboratories, Inc.
      • 10.2.3.1. Overview
      • 10.2.3.2. Products & Services
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Thermo Fisher Scientific Inc.
      • 10.2.4.1. Overview
      • 10.2.4.2. Products & Services
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. Agilent Technologies, Inc.
      • 10.2.5.1. Overview
      • 10.2.5.2. Products & Services
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. Sysmex Corporation
      • 10.2.6.1. Overview
      • 10.2.6.2. Products & Services
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Apogee Flow Systems Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products & Services
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Sony Biotechnology Inc.
      • 10.2.8.1. Overview
      • 10.2.8.2. Products & Services
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. DiaSorin S.p.A.
      • 10.2.9.1. Overview
      • 10.2.9.2. Products & Services
      • 10.2.9.3. SWOT Analysis
      • 10.2.9.4. Recent Developments
      • 10.2.9.5. Strategies
      • 10.2.9.6. Financials (Based on Availability)
    • 10.2.10. BIOMERIEUX
      • 10.2.10.1. Overview
      • 10.2.10.2. Products & Services
      • 10.2.10.3. SWOT Analysis
      • 10.2.10.4. Recent Developments
      • 10.2.10.5. Strategies
      • 10.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 2: Global Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 3: Global Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 4: Global Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Flow Cytometry Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 7: North America Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 8: North America Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 9: North America Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Flow Cytometry Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 12: Canada Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: Europe Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 14: Europe Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 15: Europe Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: Europe Flow Cytometry Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Germany Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: U.K. Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 19: France Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 20: Italy Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 21: Spain Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 22: Scandinavia Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Rest of Europe Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 24: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 25: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 26: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 27: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 28: Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 29: China Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 30: India Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 31: Japan Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 32: Australia Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 33: Southeast Asia Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 34: Rest of Asia Pacific Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 35: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, by Product & Service, 2021-2034
  • Table 36: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, by Technology, 2021-2034
  • Table 37: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 38: Rest of the World Flow Cytometry Market Revenue (USD billion) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Flow Cytometry Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Flow Cytometry Market Value Share (%), by Product & Service, 2025 & 2034
  • Figure 3: Global Flow Cytometry Market Value Share (%), by Technology, 2025 & 2034
  • Figure 4: Global Flow Cytometry Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Flow Cytometry Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Flow Cytometry Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 8: North America Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 9: North America Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 10: North America Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 11: North America Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 12: North America Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 13: North America Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 15: North America Flow Cytometry Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Flow Cytometry Market Value Share (%), By Country, 2025
  • Figure 17: Europe Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 18: Europe Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 19: Europe Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 20: Europe Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 21: Europe Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 22: Europe Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 23: Europe Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Flow Cytometry Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Flow Cytometry Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 28: Asia Pacific Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 29: Asia Pacific Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 30: Asia Pacific Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 31: Asia Pacific Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Flow Cytometry Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Flow Cytometry Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Rest of the World Flow Cytometry Market Value (USD billion), by Product & Service, 2025 & 2034
  • Figure 38: Rest of the World Flow Cytometry Market Value Share (%), by Product & Service, 2025
  • Figure 39: Rest of the World Flow Cytometry Market Value (USD billion), by Technology, 2025 & 2034
  • Figure 40: Rest of the World Flow Cytometry Market Value Share (%), by Technology, 2025
  • Figure 41: Rest of the World Flow Cytometry Market Value (USD billion), By Application, 2025 & 2034
  • Figure 42: Rest of the World Flow Cytometry Market Value Share (%), By Application, 2025
  • Figure 43: Rest of the World Flow Cytometry Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Rest of the World Flow Cytometry Market Value Share (%), by End-user, 2025
  • Figure 45: Global Flow Cytometry Market Share (%), By Company, 2025